Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Philadelphia, Pennsylvania 19107


Purpose:

This pilot clinical trial studies how well the "JeffQuit" group therapy program works in enabling patients with a history of cancer to quit smoking. The JeffQuit program uses group therapy to provide psychological support and address the mental need for smoking, the habit or routine it creates, and the physical need for nicotine. It is not yet known how well the JeffQuit program will work in helping patients with a history of cancer to stop smoking.


Study summary:

PRIMARY OBJECTIVES: I. To assess the initial effectiveness of the JeffQuit program on smoking cessation in cancer patients. II. To assess the quality of life improvements related to the JeffQuit smoking cessation program in cancer patients. OUTLINE: Patients undergo three, 1-hour group therapy sessions held by a JeffQuit practitioner over a 1-month period. Patients receive strategies for managing the psychological, habitual, and physiological components of smoking and help with developing a planned quit date. Patients are also provided with advice on how to switch to cigarette brands with less nicotine and then how to substitute the nicotine patch and gum for cigarettes. The JeffQuit counselor is available for additional individual support as needed. After completion of study, patients are followed up at 6 months.


Criteria:

Inclusion Criteria: 1. History of cancer 2. Current smoker 3. Willing to provide consent and participate in the JeffQuit program 4. Referral by a Kimmel Cancer Center provider Exclusion Criteria: 1. Any significant active medical disorder or physical condition that could reasonably be expected to interfere with the ability of the patient to quit smoking as determined by the Principal Investigator (PI) 2. Currently participating in another smoking cessation program 3. Currently receiving chemotherapy or radiation therapy that would interfere with their ability to participate in the JeffQuit program 4. Patients with evidence of a significant psychiatric disorder by history/examination that would prevent completion of the study will not be allowed to participate 5. Patients with current alcohol or drug abuse 6. Enrollment in active clinical trial/ experimental therapy within the prior 30 days 7. Are in the terminal stages of illness


NCT ID:

NCT02591433


Primary Contact:

Principal Investigator
Andrew Newberg, MD
Thomas Jefferson University


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19107
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.